Navigation Links
Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:6/12/2012

NEW YORK, June 12, 2012 /PRNewswire/ -- Galena Biopharma (Nasdaq: GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, announced today that their June 7th RetailInvestorConferences.com presentation is now available for on-demand viewing.

LINK:      www.retailinvestorconferences.com > red "register/ watch event now" button

Galena Biopharma's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq: GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.

About RetailInvestorConferences.com
Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire, and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's
'/>"/>

SOURCE Galena Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
2. Valeant Pharmaceuticals To Host Investor Day
3. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
4. Regeneron Announces June 2012 Investor Conference Presentations
5. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
6. Cell Therapeutics to Host Investor and Analyst Meeting to Discuss Targeted Agents in Myelofibrosis and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia on Sunday, June 3, 2012, in Chicago
7. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
8. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
9. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
10. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
11. Heska to Present at B. Riley Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ISPE—the International Society for Pharmaceutical Engineering ... as President and CEO, succeeding Nancy ... Society last fall.  Mr. Bournas takes the helm ... association industry as well as significant international experience.  ... for the expansion of its global initiatives and ...
(Date:7/29/2014)... (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at ... Lab Expo today by unveiling two booths (#1209 and ... with customers to redefine the value of the laboratory. ... they,re looking for a partner to help them maximize ... said Jack Phillips , president and CEO of ...
(Date:7/29/2014)... , July 29, 2014 Research and ... "Global Respiratory Devices Market 2014-2018" report to their ... A respiratory device is a medical device used ... having difficulty in breathing and cannot achieve adequate oxygen ... as cystic fibrosis, asthma, COPD, and ARDS require the ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2
(Date:7/29/2014)... 29, 2014) Using quality improvement measures in eight ... Cardiovascular Disease Study Group, researchers have found a way ... with contrast dye. , Currently, 7-15 percent of these ... end up with kidney injury, which can result in ... temporary or permanent dialysis, says a study published in ...
(Date:7/29/2014)... New York (PRWEB) July 29, 2014 ... behalf of individuals who allegedly suffered serious liver ... continue to move forward in a multidistrict litigation ... Pennsylvania, Bernstein Liebhard LLP reports. According to an ... certain deadlines pertaining to bellwether case and ...
(Date:7/29/2014)... By Alan Mozes ... -- Treating certain adult autism patients with just a single ... judge facial expressions and emotions, Japanese researchers report. Known ... a role in emotional bonding between lovers, and between mothers ... neural activity in a key area of the brain that ...
(Date:7/29/2014)... The Law Offices of Michael Cordova is proud ... non-profit organization providing grief camps for kids, teens, adults, and ... our clients experience from the death of a loved one. ... like Stepping Stones of Hope, as they provide hope and ... Hope also includes a monthly support group and a variety ...
(Date:7/29/2014)... receive steady follow-up care, the living donors themselves ... care more accessible, UC San Francisco and Walgreens ... the first program in the country that provides ... kidney donors. , UCSF will provide vouchers for ... Walgreens pharmacies and Healthcare Clinic at select Walgreens ...
Breaking Medicine News(10 mins):Health News:Reducing kidney injury using a quality improvement method 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Caring for donors 2Health News:Caring for donors 3
... unstoppable, WHO director says; U.S. health officials caution that ... widespread , THURSDAY, June 11 (HealthDay News) -- ... flu pandemic since 1968, triggered by the rapid spread ... America, Europe and regions beyond. , WHO director Dr. ...
... NeuroScience, Inc. has launched an antioxidant protocol that combines ... antioxidant compounds, including OSR#1, CysNAC, and NeuroVitamins. These products ... fat soluble and water soluble areas of the body. ... body,s supply of antioxidants, mainly glutathione, is insufficient to ...
... The National Medical Association (NMA) stands firm in its ... Obama. "AMA,s reservations are duly noted, however, competition is healthy, ... to create the competition that will lead to lower cost ... Barley Britton, president of the National Medical Association. "Public plans ...
... Calif., June 11 As a result of the ... or eliminating bonus payouts in addition to extending cost ... pay trends surveys by Aon Consulting,s Radford, a leading ... sciences industries. , , (Logo: ...
... in the June issue of the Journal of the ... by air traffic controllers tracks patient data more effectively and ... use of clipboards. Currently there is no standard practice ... the radiology suite, operating rooms, the intensive care unit, inpatient ...
... insulin resistance, study finds , THURSDAY, June 11 (HealthDay ... insulin resistance and lead to a condition known as ... outlined Thursday at the Endocrine Society,s annual meeting in ... risk for diabetes. The same team of researchers was ...
Cached Medicine News:Health News:Swine Flu Now a Pandemic 2Health News:Swine Flu Now a Pandemic 3Health News:Swine Flu Now a Pandemic 4Health News:Swine Flu Now a Pandemic 5Health News:Swine Flu Now a Pandemic 6Health News:Swine Flu Now a Pandemic 7Health News:Swine Flu Now a Pandemic 8Health News:Swine Flu Now a Pandemic 9Health News:Swine Flu Now a Pandemic 10Health News:Swine Flu Now a Pandemic 11Health News:Swine Flu Now a Pandemic 12Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 2Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 3Health News:Bonus Payout Trends and Continuing Cost Controls Reflect Challenging Business Climate, Says Aon Consulting's Radford 4Health News:Study finds air traffic control tracking method reduces errors in trauma management 2Health News:Nicotine May Help Spur 'Prediabetes' 2
... This programmable system automates the denaturation ... procedures, and provides walk-away convenience for ... cost unit accepts a wide range ... use, and reduces hands-on time by ...
... DiffSpin Slide Spinner for technique independent ... wedge smears.,DiffSpin is a compact, quiet, ... the preparation of uniformly distributed cell ... with a start-up supply of slides ...
... systems deliver pulsed light over one smooth ... spikes (which may damage skin) that other ... sends a chilled water supply through the ... which is cooled to as low as ...
... small, quiet, high-speed centrifuge. It employs a ... results in nearly vibration- free operation. Light ... speed and full breaking in a few ... a simple push-on/ pull-off; transforming the centrifuge ...
Medicine Products: